Generic Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape
The global generic injectable market is expected to grow at a CAGR of around 7.6% during 2025-2034. This report on global generic injectable market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global generic injectable market by segmenting the market based on therapeutic area, containers, distribution channel, and region. Also, detailed profiles of companies operating in the generic injectable market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Government Taking Initiatives to Support Manufacture in Various Countries • Aging Population and Rising Prevalence of Chronic Diseases • Cheaper and Shorter R&D
Market Challenges
• Contamination Concerns for Injectable Manufactured in Factories in Some Countries
Historical & Forecast Period
Base Year: 2024 Historical Period: 2020-2024 Forecast Period: 2025-2034
• Europe Germany United Kingdom France Italy Spain Russia Netherlands Rest of Europe • North America United States Canada • Asia Pacific China Japan India South Korea Australia Indonesia Rest of Asia Pacific • Latin America Mexico Brazil Argentina Rest of Latin America • Middle East & Africa Saudi Arabia Turkey Iran Rest of Middle East & Africa
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Generic Injectable Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Generic Injectable Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Generic Injectable Market by Therapeutic Area
5.1. Introduction
5.2. Oncology
5.3. Anaesthesia
5.4. Anti-infective
5.5. Parenteral Nutrition
5.6. Cardiovascular Diseases
6. Global Generic Injectable Market by Containers
6.1. Introduction
6.2. Vials
6.3. Ampoules
6.4. Premix
6.5. Prefilled Syringes
7. Global Generic Injectable Market by Distribution Channel
7.1. Introduction
7.2. Hospitals
7.3. Retail Pharmacy
8. Global Generic Injectable Market by Region
8.1 Introduction
8.2 Europe
8.2.1 Germany
8.2.2 United Kingdom
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Russia
8.2.7 Netherlands
8.2.8 Rest of the Europe
8.3 North America
8.3.1 United States
8.3.2 Canada
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 South Korea
8.4.5 Australia
8.4.6 Indonesia
8.4.7 Rest of the Asia Pacific
8.5 Latin America
8.5.1 Mexico
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 Turkey
8.6.3 Iran
8.6.4 Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1 Competitive Scenario
12.2 Company Profiles
12.2.1 Hospira (Pfizer)
12.2.2 Fresenius Kabi
12.2.3 Hikma Pharma PLC
12.2.4 Sandoz (Novartis)
12.2.5 Sagent Inc.
12.2.6 Sanofi
12.2.7 Baxter
12.2.8 Dr. Reddy Laboratories
12.2.9 Akorn Inc.
12.2.10 Fresenius SE & Co. KGaA
12.2.11 Mylan N.V.
12.2.12 Teva Pharmaceutical Industries Ltd
12.2.13 Lupin Ltd
12.2.14 Aurobindo Pharma
12.2.15 Biocon
List of Figures
Figure 1: Global Generic Injectable Market (in US$ Million), 2020-2024
Figure 2: Global Generic Injectable Market by Therapeutic Area, 2024
Figure 3: Global Generic Injectable Market by Containers, 2024
Figure 4: Global Generic Injectable Market by Distribution Channel, 2024
Figure 5: Global Generic Injectable Market by Region, 2024
Figure 6: Global Generic Injectable Market (in US$ Million), 2025-2034
Figure 7: Global Generic Injectable Market by Therapeutic Area (in %), 2024 & 2034
Figure 8: Global Oncology Generic Injectable Market (in US$ Million), 2020-2024
Figure 9: Global Oncology Generic Injectable Market (in US$ Million), 2025-2034
Figure 10: Global Anaesthesia Generic Injectable Market (in US$ Million), 2020-2024
Figure 11: Global Anaesthesia Generic Injectable Market (in US$ Million), 2025-2034
Figure 12: Global Anti-infective Generic Injectable Market (in US$ Million), 2020-2024
Figure 13: Global Anti-infective Generic Injectable Market (in US$ Million), 2025-2034
Figure 14: Global Parenteral Nutrition Generic Injectable Market (in US$ Million), 2020-2024
Figure 15: Global Parenteral Nutrition Generic Injectable Market (in US$ Million), 2025-2034
Figure 16: Global Cardiovascular Diseases Generic Injectable Market (in US$ Million), 2020-2024
Figure 17: Global Cardiovascular Diseases Generic Injectable Market (in US$ Million), 2025-2034
Figure 18: Global Generic Injectable Market by Containers (in %), 2024 & 2034
Figure 19: Global Vials Generic Injectable Market (in US$ Million), 2020-2024
Figure 20: Global Vials Generic Injectable Market (in US$ Million), 2025-2034
Figure 21: Global Ampoules Generic Injectable Market (in US$ Million), 2020-2024
Figure 22: Global Ampoules Generic Injectable Market (in US$ Million), 2025-2034
Figure 23: Global Premix Generic Injectable Market (in US$ Million), 2020-2024
Figure 24: Global Premix Generic Injectable Market (in US$ Million), 2025-2034
Figure 25: Global Prefilled Syringes Generic Injectable Market (in US$ Million), 2020-2024
Figure 26: Global Prefilled Syringes Generic Injectable Market (in US$ Million), 2025-2034
Figure 27: Global Generic Injectable Market by Distribution Channel (in %), 2024 & 2034
Figure 28: Global Hospitals Generic Injectable Market (in US$ Million), 2020-2024
Figure 29: Global Hospitals Generic Injectable Market (in US$ Million), 2025-2034
Figure 30: Global Retail Pharmacy Generic Injectable Market (in US$ Million), 2020-2024
Figure 31: Global Retail Pharmacy Generic Injectable Market (in US$ Million), 2025-2034
Figure 32: Global Generic Injectable Market by Region (in %), 2024 & 2034
Figure 33: Europe Generic Injectable Market (in US$ Million), 2020-2024
Figure 34: Europe Generic Injectable Market (in US$ Million), 2025-2034
Figure 35: Europe Generic Injectable Market by Country (in %), 2024 & 2034
Figure 36: Germany Generic Injectable Market (in US$ Million), 2020-2034
Figure 37: United Kingdom Generic Injectable Market (in US$ Million), 2020-2034
Figure 38: France Generic Injectable Market (in US$ Million), 2020-2034
Figure 39: Italy Generic Injectable Market (in US$ Million), 2020-2034
Figure 40: Spain Generic Injectable Market (in US$ Million), 2020-2034
Figure 41: Russia Generic Injectable Market (in US$ Million), 2020-2034
Figure 42: Netherlands Generic Injectable Market (in US$ Million), 2020-2034
Figure 43: North America Generic Injectable Market (in US$ Million), 2020-2024
Figure 44: North America Generic Injectable Market (in US$ Million), 2025-2034
Figure 45: North America Generic Injectable Market by Country (in %), 2024 & 2034
Figure 46: United States Generic Injectable Market (in US$ Million), 2020-2034
Figure 47: Canada Generic Injectable Market (in US$ Million), 2020-2034
Figure 48: Asia Pacific Generic Injectable Market (in US$ Million), 2020-2024
Figure 49: Asia Pacific Generic Injectable Market (in US$ Million), 2025-2034
Figure 50: Asia Pacific Generic Injectable Market by Country (in %), 2024 & 2034
Figure 51: China Generic Injectable Market (in US$ Million), 2020-2034
Figure 52: Japan Generic Injectable Market (in US$ Million), 2020-2034
Figure 53: India Generic Injectable Market (in US$ Million), 2020-2034
Figure 54: South Korea Generic Injectable Market (in US$ Million), 2020-2034
Figure 55: Australia Generic Injectable Market (in US$ Million), 2020-2034
Figure 56: Indonesia Generic Injectable Market (in US$ Million), 2020-2034
Figure 57: Latin America Generic Injectable Market (in US$ Million), 2020-2024
Figure 58: Latin America Generic Injectable Market (in US$ Million), 2025-2034
Figure 59: Latin America Generic Injectable Market by Country (in %), 2024 & 2034
Figure 60: Mexico Generic Injectable Market (in US$ Million), 2020-2034
Figure 61: Brazil Generic Injectable Market (in US$ Million), 2020-2034
Figure 62: Argentina Generic Injectable Market (in US$ Million), 2020-2034
Figure 63: Middle East & Africa Generic Injectable Market (in US$ Million), 2020-2024
Figure 64: Middle East & Africa Generic Injectable Market (in US$ Million), 2025-2034
Figure 65: Middle East & Africa Generic Injectable Market by Country (in %), 2024 & 2034
Figure 66: Saudi Arabia Generic Injectable Market (in US$ Million), 2020-2034
Figure 67: Turkey Generic Injectable Market (in US$ Million), 2020-2034
Figure 68: Iran Generic Injectable Market (in US$ Million), 2020-2034
Figure 69: Market Value Chain
List of Tables
Table 1: Global Generic Injectable Market Portraiture
Table 2: Global Generic Injectable Market by Therapeutic Area (in US$ Million), 2024 & 2034
Table 3: Global Generic Injectable Market by Containers (in US$ Million), 2024 & 2034
Table 4: Global Generic Injectable Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 5: Global Generic Injectable Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Generic Injectable Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Generic Injectable Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Generic Injectable Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Generic Injectable Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Generic Injectable Market by Country (in US$ Million), 2024 & 2034